Technology Results for "Medical"

Available Technologies

07HSC007 A New Method for Screening for Autoantibodies Against Receptors

07HSC010 Use of statins that are currently FDA approved for cholesterol reduction inhibit hepatitis C and hepatitis B viral replication in vivo and improve sustained viral remission when combined with interferon and will improve liver disease when used ...

06HSC039 Inhibition of the epidermal growth factor receptor exerts a cytoprotective effect in the gastric mucosa

07HSC005 Modified Nasogastric Feeding Tube

07HSC013 Determination of Rab5 Activity (Rab5-GTP level) in the Cell by Effector Pull-Down Assay

07HSC021 New Glycosaminoglycan Degradation Assays and Substrates

07HSC024 Method of targeted depletion of gastrointestinal and cancer stem cells

07HSC017 Use of Self Compacted DNA Nanoparticles for Ocular Diseases

02NOR022 Development of Intracellular Inhibitors of Bacterial Toxins

99NOR006 Microencapsulated Plasminogen Activator

05NOR026 3-Dimensional Finite Element Computational Model of Human Ear

05NOR002 Water Repellent Cotton Fabric Composite

04NOR049 Efficient Synthesis of Hypothiocyanite

04NOR036 Tissue Engineering Vascular Grafts Using the Umbilical Vein as a Decellularised Matrix and a Rapid Bioreactor-Based Autologus Cell Seeding Technology for Bypass Surgery

04NOR005 Implantable Coil for Hearing Aid Devices

03NOR061 Phase and Phase Contrast X-Ray Imaging Techniques

03NOR041 Brain Machine Interface: Micro Recording Device

03NOR036 Cytotoxic Agent Targeted to Cancer Cells

04HSC007 Gene Expression by Retinal Capillary Pericytes/Smooth Muscle Cells after Exposure to Modified Low Density Lipoproteins (LDL)

07NOR032 Recognizing and Reshaping the modulatory personality: A new approach to understanding and treating mental disorders

07NOR029 A new approach to understanding and treating schizophrenia

07NOR023 BMI Insertion Device

07NOR004 New Cancer Treatment Aimed at Destruction of Cancer Tumors

05TUL024 Diagnostic Method for Screening Complement Regulatory Protein Levels

05HSC047 Nanoceria Particles Provide Neuronal Protection in Retinal Cells

06HSC013 Enzyme Immunoassay for Complement Fixing Anti-Phospholipid Antibodies

06HSC014 Role of Cosmc in Human Diseases and Disorder

05HSC011C Image Viewer and Analysis Toolkit for Tumors that enable Rapid Development and Evaluation of Dynamic Contrast Imaging over Serial Treatment Evaluation

05HSC006 661W A Cone Photoreceptor Cell Line

05HSC003 Activation of cardiac alpha receptors by spinal cord stimulation produces cardioprotection against ischemia, arrhythmias, and heart failure

04HSC001 A Cell-Based Assay for Small Molecule Inhibitors of the Mitotic Spindle Checkpoint/Metaphase Checkpoint Pathway

03HSC019 Detection of a Single Nucleotide Polymorphism that Results in Arg6Trp in a2AP

03HSC018 Discovery of a Novel Enzyme that Enhances the Proficiency of a2-antiplasmin as an Inhibitior of Blood Clot Removal

01HSC024 Derivatives of Clostridium septicum alpha toxin with potential for vaccine development

00HSC016 In Vitro, Tissue Engineered, Regenerated Urinary Tract Organs

97NOR010 New Fusion Protein Systems Designed to Increase Soluble Cytoplasmic Expression of Heterologous Proteins in E. Coli

05TUL023 Diagnostic Method for Screening Complement Regulatory Protein levels to Predict Spontaneous Abortion

95HSC021 Iontophoretic Transdermal Delivery Device

06HSC007 Generalizable Method for Searching for Assembly-Directed Antiviral Compounds

06HSC006 A Serine Kinase Inhibitor as a Novel Anthrax Therapeutic

06HSC003 Identification of Drugs to Target Suppressed Cancer Cells

05HSC050 Identification of Tumor-Specific Sequences and Alterations in Immune Responses in Peripheral Blood Circulating Cells of Cancer-Bearing Patients for Cancer Screening

05HSC049 Vaccine against West-Nile Virus

05HSC045 Versatile Derivatization of Glycans for Glycomic Analysis

05HSC043 Novel Heteroarotinoids as Potential Inhibitors of Human PKD

05TUL025 Non-Human Model for Human Endometriosis

05HSC042 A Single Primer-Extension Based Assay for the Detection of DNA Damage

05HSC040 Prevention of Cancer by Reversing Abnormal Differentiation and Inducing Apoptosis

05HSC039 Induction of Apoptosis Through Regulation of Gene Expression

05HSC038 Regulation of the Hepatocyte Nuclear Factor-4 (HNF-4) Receptor

05HSC037 Inhibition of Angiogenesis and Expression of Genes Involved in Blood Vessels

05HSC018 Evaluation Methodology for Contrast Uptake in Tumors

05HSC016 Apparatus and Means for Stereotactic Localization of Spinal Segments

05HSC014C Online Educational Case Study Template

06HSC017 Use of Biofilm Lysine Decarboxylase Activity to Detect 'Refractory' Chronic Peridontitis

06HSC018 Antiarrhythmic actions of cisatracurium

06HSC024 Modification of Small Intestinal Submucosa (SIS) to Provide Uniform Structure and to Deliver Macromolecules for Efficient Tissue Regeneration

06HSC026 Biochemical Diagnosis of 'Refractory' Chronic Periodontitis

06HSC027 Improved Method for Correction of Systematic Bias Introduced by the Sub-voxel Image Registration Process in Functional Magnetic Resonance Imaging (fMRI)

06HSC028 Interferon Gamma Inhibition of Herpes Virus Infection

06HSC040 Blood Test for Pancreatic Cancer

03NOR004 Brain Machine Interface: Micro Stimulator Device

Licensed Technologies

06HSC051 DNA Sequencing Software

07HSC026 Use of a novel curcumin analog to treat colon cancer

06HSC029 Hyaluronan Synthase/Transporter Technology for HA Production

07HSC034 Obtain interpretable DNA sequence immediately adjacent to a synthetic DNA sequencing primer

06HSC008C Family as Context for Clinical Genetics: A Web-based Curriculum for Health Care Professionals--Breast and Ovarian Cancer Learning Module

05HSC048 Accelerated Class I and Class II HLA DNA Sequence-Based Typing

07NOR001 New Cancer Treatment Aimed at Destruction of Cancer Tumors [With Nomadics Info]

01HSC039 Relief of Chronic Pain via Peripheral Neurotransmitter Regulation

98HSC021 Lysine Decarboxylase Inhibitors for Prevention and Treatment of Periodontal Disease

05HSC012 Development and Use of a Chimeric Protein for Therapy of Bleeding Disorders and Cancer

04HSC034 Mixed-Bed Lectin Chromatography

04HSC016 Antioxidant Agents Used in combination with or Chemically Linked to Mesalamine for The Treatment of Inflammatory Bowel Disease

03HSC010 Relief of Pain via Peripheral Neurotransmitter Regulation

06NOR034 New Cancer Treatment Aimed at the Detection and Destruction of Cancer Tumors

05HSC044 Assay for Retrovirus Maturation Inhibitors

05HSC052 Treatment of Ocular Infections and Wounds by CAP37

06HSC009C Family as Context for Clinical Genetics: A Web-based Curriculum for Health Care Professionals--Cystic Fibrosis Learning Module

06HSC050 PCR Specificity Enhancement and Deletion Sequencing Technologies

07HSC015 Vaccine to help prevent periodontal disease in dogs

07HSC012 Production of Defined Monodisperse Heparosan Polymers and Unnatural Polymers with Polysaccharide Synthases